Novo Nordisk relies on and is grateful to the many people who are willing to donate biosamples for use in research. Human biosamples are obtained from donor banks, tissue biobanks, or individuals participating in biomedical research projects and clinical trials via collaborating universities, hospitals and other research organisations. Research using human biosamples is done at Novo Nordisk’s own facilities and in collaboration with external partners.
Novo Nordisk takes a responsible approach by addressing the bioethics issues in relation to the acquisition, storage and use of human biosamples. Biosamples used by Novo Nordisk are obtained from individual countries and these are governed by national laws and international conventions. Although variations exist in local laws, cultures, customs and practices, internationally common principles provide the foundation for Novo Nordisk’s position. All Novo Nordisk’s research work using human biosamples must align with this position.
Novo Nordisk continuously reviews its bioethics standards and conduct relating to the acquisition and use of human biosamples and interacts with regulatory bodies and other key stakeholders to maintain and further develop the appropriate ethics standards at an international level.
Brian J Clark
Global Head of Biobanking